Press Releases July 28, 2026 09:15 AM

STRATA Skin Sciences Appoints Medical Device Commercial Leader Erica Jordan as Chief Executive Officer

STRATA Skin Sciences Names Erica Jordan as New CEO to Lead Commercial Expansion

By Leila Farooq
Share
Twitter Reddit Facebook LinkedIn
SSKN

STRATA Skin Sciences, a U.S.-based medical technology company specializing in excimer laser therapy for dermatologic conditions, has appointed Erica Jordan as its new CEO effective July 12, 2026. With extensive experience in commercial leadership in medical device and healthcare sectors, Jordan is expected to drive the company’s growth by scaling its commercial operations and expanding access to its therapies.

STRATA Skin Sciences Appoints Medical Device Commercial Leader Erica Jordan as Chief Executive Officer
SSKN
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Appointment of Erica Jordan, an experienced medical device commercial leader, as CEO to lead STRATA Skin Sciences into its next growth phase.
  • Focus on expanding the commercial reach of STRATA’s dermatologic treatment technologies, leveraging established clinical outcomes and reimbursement structures.
  • The company’s unique Partnership Program reduces capital barriers for dermatology practices, facilitating wider adoption of its products such as the XTRAC excimer laser and TheraClear Acne Therapy System.

HORSHAM, Pa., July 28, 2026 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”), a global leader in excimer laser therapy dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, has appointed industry veteran Erica Jordan as Chief Executive Officer, effective July 12, 2026.

STRATA chairperson Dr. Uri Geiger stated, “Erica has a proven record of expanding and transforming sales operations in large markets. We look forward to collaborating closely with Erica as she brings STRATA into its next era and translates the historical expanded CPT Code coverage into commercial success. I also want to thank Dr. Dolev Rafaeli for his long tenure as CEO and building the foundation of Strata Skin Sciences”

Erica Jordan is a strategic commercial leader with a focus on partnering with providers to enable care and improve business practices. She is well versed in revitalizing organizations by increasing revenue, scaling operations, expanding markets, transforming sales and commercial teams, and launching innovative products and services in diverse markets. She has demonstrated a long-standing commitment to cross-functional collaboration and meaningful customer engagement, excelling in aligning teams with shared goals and navigating matrix organizations to achieve corporate objectives.

"STRATA has what many companies spend years trying to build: proven clinical outcomes, established reimbursement, and a commercial partnership model that removes the capital barrier for dermatology practices," said Ms. Jordan. "My focus will be on scaling the commercial organization so that more practices — and ultimately more patients who are candidates for these therapies — have access to them."

Prior to joining STRATA, Ms. Jordan served as Chief Commercial Officer for Revance Therapeutics, spearheading sales, marketing (B2B and B2C), operations, corporate communications, investor relations, corporate strategy, and business excellence in domestic and international markets. Prior, she served as Metrex president at Envista Holdings (former Danaher Company). She has held leadership positions within the sales and marketing functions at leading organizations, including Change Healthcare (now part of Optum), Philips Healthcare, Fujifilm Medical, Siemens Medical Solutions, and GE Healthcare. She holds a Bachelor of Science degree in Marketing from the University of Wisconsin- Milwaukee.

About STRATA Skin Sciences, Inc.

STRATA Skin Sciences is a medical technology company dedicated to developing, commercializing, and marketing innovative products for the in-office treatment of various dermatologic conditions, such as psoriasis, vitiligo, and acne. Its products include the XTRAC® excimer laser, VTRAC® lamp systems, and the TheraClear®X Acne Therapy System. STRATA is proud to offer these exciting technologies in the U.S. through its unique Partnership Program. STRATA’s popular partnership approach includes a fee per treatment cost structure versus an equipment purchase, installation and use of the device, on-site training for practice personnel, service and maintenance of the equipment, dedicated account and customer service associates, and co-op advertising support to help raise awareness and promote the program within the practice.

Safe Harbor

This press release includes “forward-looking statements” within the meaning of the Securities Litigation Reform Act of 1995. These statements involve known and unknown risks and uncertainties that may cause actual results to differ materially from those expressed or implied by such statements. STRATA Skin Sciences undertakes no obligation to publicly update or revise any forward-looking statements.

Contact

STRATA Skin Sciences, Inc.

5 Walnut Grove Drive, Suite 140, Horsham, PA 19044

(215) 619-3200 | [email protected] | strataskinsciences.com


Risks

  • The press release includes forward-looking statements subject to risks and uncertainties that could lead to actual results differing materially, including market acceptance and operational scaling challenges.
  • Potential challenges in scaling commercial operations effectively across diverse markets may impact revenue growth projections.
  • Dependence on continued reimbursement for treatments and successful partnership adoption by dermatology practices may pose risks if market dynamics change.

More from Press Releases

Rubico Announces Acquisition of 3rd Newbuilding MR Tanker and a 24% Increase of Potential Gross Revenue Backlog to About $379 Million Jul 28, 2026 ABM and LaGuardia Gateway Partners Launch Autonomous Robotics Pilot at Terminal B, Setting a New Standard for Airport Guest Experience Jul 28, 2026 BiomX And Water.IO Agree To Updated Zorronet Acquisition Terms Jul 28, 2026 Shimmick Corporation to Announce Second Quarter 2026 Financial Results on August 10, 2026 Jul 28, 2026 Freight Technologies Expands Fleet Rocket to 92 Integrated GPS Providers Jul 28, 2026